SOVREMENNYE PREDSTAVLENIYa O TERAPII MOChEVYKh INFEKTsIY U DETEY


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The problem of diagnosis and treatment of acute urinary tract infection (UTI) among febrile children remains relevant in connection with a large prevalence of the nosology and the growth of antibiotic resistance. The need for antibiotics in the treatment of acute UTI in children is also practically assured. The duration of therapy remains debatable, since the exact topical diagnosis in infants is usually difficult. The effectiveness of treatment of acute UTI in infants does not depend on the method of starting administration of antibacterial drug, but depends on the dose that ensures the achievement of minimum inhibitory concentration. Protected aminopenicillins, as well as II and III generation cephalosporins are drugs of choice. In children with acute UTI who received antibiotic therapy during the previous period of the disease, as well as in suspected obstructive uropathy, uropathogens with high resistance to aminopenicillins, including protected aminopenicillins, are most likely causative agents. In such cases, the II-III generation cephalosporin should be the drug of choice.

Full Text

Restricted Access

About the authors

I. L Chashchina

References

  1. Winberg J, Bergstrom T, Jacobsson B. Morbidity, age and sex distribution, recurrences and renal scarring in symptomatic urinary tract infection in childhood. Kidney Int Suppl 1975;4:101-06.
  2. Бакрадзе М.Д. Новые лечебно-диагностические и организационные технологии ведения детей с острыми лихорадочными заболеваниями. Дисс. докт. мед. наук. М., 2009.
  3. Smellie J.M, Katz G, Gruneberg R.N. Controlled trial of prophylactic treatment in childhood urinary tract infection. Lancet 1978;2(28082): 174-75.
  4. Dick P.T, Feldman W. Routine diagnostic imaging for childhood urinary tract infections: a systematic overview. J Pediatr 1996;128(1):15-8.
  5. Ginsburg C.M, McCracken G.H. Urinary tract infections in young infants. J Pediatr 1982;69(4):409-12.
  6. Моисеев С.В. Практические рекомендации по антибактериальной терапии и профилактике ИМП с позиции доказательной медицины // Инфекции и антимикробная терапия 2005;5(3):89-94.
  7. Цыгин А.Н., Комарова О.В., Сергеева Т.В. и др. Инфекция мочевыводящих путей. Клинические рекомендации: Педиатрия / Под ред. А.А. Баранова. М., 2005. С. 81-96.
  8. Klar A, Hurvitz H, Berkun Y, et al. Focal bacterial nephritis (lobar nephronia) in children. J Pediatr 1996;128(6):850-53.
  9. Kline M.W. Pathogenesis of brain abscess caused by Citrobacter diversus or Enterobacter sakazakii. Pediatr Infect Dis J 1988;7(12):891-92.
  10. Cheng C.H, Chiu C.H. Urinary tract infection in children: incidence of vesicoureteral reflux, imaging studies, and antimicrobial resistance among E. coli. Acta Paediatr Taiwan 2004;45(6):313-4.
  11. Lindsay E. Asymptomatic bacteriuria - important or not? N Engl J Med 2000;343(14):1037-39.
  12. Pewitt E.B, Schaeffer A.J. Urinary tract infection in urology, including acute and chronic prostatitis. Infect Dis Clin North Am 1997; 11(3):623-46.
  13. Reid G, Bruce A.W. Could probiotics be an option for treating and preventing urogenital infections? Medscape Womens Health 2001;6(5):9.
  14. Grabe M, Bjerklund-Johansen T.E, Botto H, et al. Guidelines on urological infections. EAU Guidelines edition, 2011.
  15. Lohr J.A. Use of routine urinalysis in making a presumptive diagnosis of urinary tract infection in children. Pediatr Infect Dis J 1991; 10:645-46.
  16. Kemper K.J, Avner E.D. The case against screening urinalyses for asymptomatic bacteriuria in children. Am J Dis Child 1992;146:343-44.
  17. Burns M.W, Burns J.L, Krieger J.N. Pediatric urinary tract infection. Diagnosis, classification, and significance. Pediatr Clin North Am 1987; 34:1110-11.
  18. Рафальский В.В. Антибактериальная терапия острой гнойной инфекции почек // Consilium medicum 2006. Т. 4. № 8. С. 5-8.
  19. Страчунский Л.С., Рафальский В.В. Клиническое значение и антибактериальная терапия острых циститов // Клиническая антимикробная химиотерапия 1999. Т. 3. № 1. С. 84-91.
  20. Скала Л., Сидоренко С., Нехорошева А. и др. Практические аспекты современной клинической микробиологии М., 2004. 310 с.
  21. Карпов О.И. Фармакоэкономическая изнанка комплаенса основных препаратов сульфонилмочевины // Трудный пациент 2006. № 10. С. 50.
  22. Цыгин А.Н. и соавт. Инфекция мочевыводящих путей // Педиатрическая фармакология 2006. Т. 3. № 3. С. 39.
  23. Conway P.H, Cnaan A, Zoontis T, et al. Recurrent urinary tract infections in children: risk factors and association with prophylactic antimicrobials. JAMA 2007;298(2):179-86.
  24. Piepsz A, Tamminen-Mobius T, Reiners C, et al. Five-year study of medical or surgical treatment in children with severe vesico-ureteral reflux dimercaptosuccinic acid findings. International Reflux Study Group in Europe. Eur J Pediatr 1998;157(9):753-58.
  25. Bouisson F, Munzer C, Decramer S, et al. Prospective, randomized trial comparing short and long intravenous antibiotic treatment of acute pyelonephritis in children: dimercaptosuccinic acid scintigraphic evaluation at 9 months. J Pediatr 2008;121(3):553-60.
  26. Doganis D, Siatas K, Mavrikou S, et al. Does early treatment of urinary tract infection prevent renal damage? J Pediatr 2007;120(4): 922-28.
  27. Bauernfeind A. Ceftibuten bactericidal kinetics. Comparative in vitro activity against clinical isolates from West Germany. Diagnos Microbiol Infect Dis 1991;14:63- 74.
  28. Debbia E.A, Schito G.C, Pesce A, et al. Antibacterial activity of Ceftibuten a new oral third generation cephalosporin. J Chemotherapy 1991;3:209-55.
  29. Blumer J.L, Linder C.W, Nelson K, et al. Comparative evaluation of cefadroxil and cephalexin in children and adolescents with pyodermas. Cefadroxil Once Daily Pyoderma Study Group. Clin Ther 1993;15(1):46-56.
  30. Rodewald L.E, Pichichero M.E. Compliance with antibiotic therapy: a comparison of deuterium oxide tracer, urine bioassay, bottle weights, and parental reports. J Pediatr1993;123(1):143-47.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2013 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies